Abstract
Ellagic acid is a natural anti-oxidant phenol found in numerous fruits and vegetables, in particular pomegranate, persimmon, raspberry, black raspberry, strawberry, peach, plumes, nuts (walnuts, almonds), and wine. The anti-proliferative and anti-oxidant properties of ellagic acid have prompted research into its potential health benefits. The aim of this chapter will be to summarize potential benefits of ellagic acid supplementation in chronic diseases.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Zamora-Ros R, Knaze V, Luján-Barroso L, Slimani N, Romieu I, Fedirko V, de Magistris MS, Ericson U, Amiano P, Trichopoulou A, Dilis V, Naska A, Engeset D, Skeie G, Cassidy A, Overvad K, Peeters PH, Huerta JM, Sánchez MJ, Quirós JR, Sacerdote C, Grioni S, Tumino R, Johansson G, Johansson I, Drake I, Crowe FL, Barricarte A, Kaaks R, Teucher B, Bueno-de-Mesquita HB, van Rossum CT, Norat T, Romaguera D, Vergnaud AC, Tjønneland A, Halkjær J, Clavel-Chapelon F, Boutron-Ruault MC, Touillaud M, Salvini S, Khaw KT, Wareham N, Boeing H, Förster J, Riboli E, González CA (2011) Estimated dietary intakes of flavonols, flavanones and flavones in the European Prospective Investigation into Cancer and Nutrition (EPIC) 24 hour dietary recall cohort. Br J Nutr 106(12):1915–1925
Seeram NP, Zhang Y, McKeever R, Henning SM, Lee RP, Suchard MA, Li Z, Chen S, Thames G, Zerlin A, Nguyen M, Wang D, Dreher M, Heber D (2008) Pomegranate juice and extracts provide similar levels of plasma and urinary ellagitannin metabolites in human subjects. J Med Food 11(2):390–394
Larrosa M, Tomás-Barberán FA, EspÃn JC (2006) The dietary hydrolysable tannin punicalagin releases ellagic acid that induces apoptosis in human colon adenocarcinoma Caco-2 cells by using the mitochondrial pathway. J Nutr Biochem 17(9):611–625
Gil MI, Tomás-Barberán FA, Hess-Pierce B, Holcroft DM, Kader AA (2000) Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing. J Agric Food Chem 48(10):4581–4589
Bala I, Bhardwaj V, Hariharan S, Kumar MN (2006) Analytical methods for assay of ellagic acid and its solubility studies. J Pharm Biomed Anal 40(1):206–210
MarÃn M, Giner RM, RÃos JL, Recio MC (2013) Intestinal anti-inflammatory activity of ellagic acid in the acute and chronic dextrane sulfate sodium models of mice colitis. J Ethnopharmacol 150(3):925–934
Rosillo MA, Sánchez-Hidalgo M, Cárdeno A, Aparicio-Soto M, Sánchez-Fidalgo S, Villegas I, de la Lastra CA (2012) Dietary supplementation of an ellagic acid-enriched pomegranate extract attenuates chronic colonic inflammation in rats. Pharmacol Res 66(3):235–242
Umesalma S, Sudhandiran G (2011) Ellagic acid prevents rat colon carcinogenesis induced by 1, 2 dimethyl hydrazine through inhibition of AKT-phosphoinositide-3 kinase pathway. Eur J Pharmacol 660(2–3):249–258
Xu YM, Deng JZ, Ma J, Chen SN, Marshall R, Jones SH, Johnson RK, Hecht SM (2003) DNA damaging activity of ellagic acid derivatives. Bioorg Med Chem 11:1593–1596
Devipriya N, Sudheer AR, Menon VP (2007) Dose-response effect of ellagic acid oncirculatory antioxidants and lipids during alcohol-induced toxicity in experimental rats. Fundam Clin Pharmacol 21:621–630
Singh K, Khanna AK, Chander R (1999) Hepatoprotective activity of ellagic acid carbon tetrachloride induced hepatotoxicity in rats. Indian J Exp Biol 37:1025–1026
Yu YM, Chang WC, Wu CS, Chiang SY (2005) Reduction of oxidative stress and apoptosis in hyperlipidemic rabbits by ellagic acid. J Nutr Biochem 16:675–681
Pathak RK, Baunthiyal M, Taj G, Kumar A (2014) Virtual screening of natural inhibitors to the predicted HBx protein structure of Hepatitis B Virus using molecular docking for identification of potential lead molecules for liver cancer. Bioinformation 10:428–435
Reddy BU, Mullick R, Kumar A, Sudha G, Srinivasan N, Das S (2014) Small molecule inhibitors of HCV replication from Pomegranate. Sci Rep 4:1–10
Ajala OS, Jukov A, Ma CM (2014) Hepatitis C virus inhibitory hydrolysable tanninsfrom the fruits of Terminalia chebula. Fitoterapia 99:117–123
Ulrich P, Cerami A (2001) Protein glycation, diabetes, and aging. Recent Prog Horm Res 56:1–21
Yan SD, Chen X, Fu J, Chen M, Zhu H, Roher A, Slattery T, Zhao L, Nagashima M, Morser J, Migheli A, Nawroth P, Stern D, Schmidt AM (1996) RAGE and amyloid-beta peptide neurotoxicity in Alzheimer’s disease. Nature 382(6593):685–691
Srikanth V, Maczurek A, Phan T, Steele M, Westcott B, Juskiw D, Münch G (2011) Advanced glycation endproducts and their receptor RAGE in Alzheimer’s disease. Neurobiol Aging 32(5):763–777
Liu W, Ma H, Frost L, Yuan T, Dain JA, Seeram NP (2014) Pomegranate phenolics inhibit formation of advanced glycation endproducts by scavenging reactive carbonyl species. Food Funct 5(11):2996–3004
Rojanathammanee L, Puig KL, Combs CK (2013) Pomegranate polyphenols and extract inhibit nuclear factor of activated T-cell activity and microglial activation in vitro and in a transgenic mouse model of Alzheimer disease. J Nutr 143(5):597–605
Fatima N, Hafizur RM, Hameed A, Ahmed S, Nisar M, Kabir N (2015) Ellagic acid in Emblica officinalis exerts anti-diabetic activity through the action on β-cells of pancreas. Eur J Nutr. doi:10.1007/s00394-015-1103-y
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Derosa, G., Maffioli, P., Sahebkar, A. (2016). Ellagic Acid and Its Role in Chronic Diseases. In: Gupta, S., Prasad, S., Aggarwal, B. (eds) Anti-inflammatory Nutraceuticals and Chronic Diseases. Advances in Experimental Medicine and Biology, vol 928. Springer, Cham. https://doi.org/10.1007/978-3-319-41334-1_20
Download citation
DOI: https://doi.org/10.1007/978-3-319-41334-1_20
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-41332-7
Online ISBN: 978-3-319-41334-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)